The advancement of software, artificial intelligence (AI), and data science has been crucial to the success of today's biotech and healthcare industries. Electronic health records (EHRs), Laboratory Information Management Systems (LIMS), and Clinical Trial Management Systems (CTMS) have been game-changing advancements to streamline the gathering and sharing of information from labs to patients. Bioinformatics and molecular modeling software are continuing to revolutionize drug discovery and development. It’s an exciting time for healthcare, driven by the ongoing merging of computer science and biology!
While the integration of computer science and biology is yielding groundbreaking advancements in biotechnology, the two fields speak different languages and the merging can sometimes be complicated. One challenge is keeping biologists informed on the latest developments in computer science, such as artificial intelligence and machine learning. Decision makers that will potentially adopt new technology can be curious about what’s inside the black box, but they are much more interested in the end results. What new feat can they achieve with your new software? Are there concrete and tangible benefits? What kind of staff is needed to run the new system?
To teach and persuade biotech, one must speak their language. It’s critical for the people writing and editing inter-science communication to understand both sides and translate for the appropriate audience. Biofluent writers are adept at translating complex scientific content to a range of audiences. Many of our writers have first hand knowledge of bioinformatic software, information management systems, and AI tools. Trust us to communicate your message effectively.